Literature DB >> 4092188

The phase II trial.

R E Wittes, S Marsoni, R Simon, B Leyland-Jones.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 4092188

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  5 in total

1.  Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumors. A phase II study from the Pediatric Oncology Group.

Authors:  F Kung; F A Hayes; J Krischer; D Mahoney; B Leventhal; G Brodeur; D H Berry; R Dubowy; S Toledano
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850

Review 2.  Combination chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.

Authors:  S Martino; B A Samal; B Redman; L Flaherty; M Kraut; M Simon; M Valdivieso
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

4.  From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development.

Authors:  Deborah B Doroshow; James H Doroshow
Journal:  Cancer J       Date:  2019 Jul/Aug       Impact factor: 3.360

5.  Phase II trial of mitoxantrone in acute lymphocytic leukemia of childhood. A Pediatric Oncology Group study.

Authors:  M L Graham; J Estrada; A H Ragab; K A Starling; D Rosen; R W Wilkenson; R W Wilkerson
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.